Vaccination-based exposure to spike protein derived from early SARS-CoV-2 sequences is
the key public health strategy against COVID-19. Successive waves of SARS-CoV-2 …

Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health
response to COVID-19. The emergence of hypermutated, increasingly transmissible variants …

Remdesivir (RDV), a broadly acting nucleoside analogue, is the only FDA approved small
molecule antiviral for the treatment of COVID-19 patients. To date, there are no reports …

The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide …

At the end of 2021 a new SARS-CoV-2 variant, Omicron, emerged and quickly spread across
the world. It has been demonstrated that Omicron’s high number of Spike mutations lead to …

Spillover events of avian influenza A viruses (IAVs) to humans could represent the first step
in a future pandemic 1 . Several factors that limit the transmission and replication of avian …

… Wilhelm Furnon … MacLean, Craig Wilkie, Giuditta De Lorenzo, Wilhelm Furnon, Diego
Cantoni, Sam Scott, Nicola Logan and Shirin Ashraf contributed equally and that John Haughney …

The appearance of new dominant variants of concern (VOC) of severe acute respiratory
syndrome coronavirus type 2 (SARS-CoV-2) threatens the global response to the coronavirus …

SARS-CoV-2 has a broad mammalian species tropism infecting humans, cats, dogs, and
farmed mink. Since the start of the 2019 pandemic, several reverse zoonotic outbreaks of SARS…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) human adaptation
resulted in distinct lineages with enhanced transmissibility called variants of concern (VOCs). …